151 related articles for article (PubMed ID: 34344240)
1. Cost of microvascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil.
Julian GS; Accetturi Pititto LM; Miresashvili N; Broe Honoré J; Lopes Assis Coelho RC; Campos D
J Med Econ; 2021; 24(1):1002-1010. PubMed ID: 34344240
[TBL] [Abstract][Full Text] [Related]
2. Cost of macrovascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil.
Julian GS; Campos D; Broe Honore J; Sauer Tobaruella F; Hyun Yoon J; Hallén N
J Med Econ; 2020 Sep; 23(9):985-993. PubMed ID: 32372710
[No Abstract] [Full Text] [Related]
3. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
4. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study.
Osme SF; Almeida APS; Lemes MF; Barbosa WO; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
J Hosp Infect; 2020 Oct; 106(2):303-310. PubMed ID: 32693085
[TBL] [Abstract][Full Text] [Related]
5. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China.
Chen D; Liu S; Tan X; Zhao Q
BMC Health Serv Res; 2017 Mar; 17(1):199. PubMed ID: 28288623
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.
Sogayar AM; Machado FR; Rea-Neto A; Dornas A; Grion CM; Lobo SM; Tura BR; Silva CL; Cal RG; Beer I; Michels V; Safi J; Kayath M; Silva E;
Pharmacoeconomics; 2008; 26(5):425-34. PubMed ID: 18429658
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
8. Estimated hospitalizations attributable to diabetes mellitus within the public healthcare system in Brazil from 2008 to 2010: study DIAPS 79.
Rosa R; Nita ME; Rached R; Donato B; Rahal E
Rev Assoc Med Bras (1992); 2014; 60(3):222-30. PubMed ID: 25004267
[TBL] [Abstract][Full Text] [Related]
9. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates.
Al-Maskari F; El-Sadig M; Nagelkerke N
BMC Public Health; 2010 Nov; 10():679. PubMed ID: 21059202
[TBL] [Abstract][Full Text] [Related]
11. The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.
Maia Diniz I; Guerra AA; Lovato Pires de Lemos L; Souza KM; Godman B; Bennie M; Wettermark B; de Assis Acurcio F; Alvares J; Gurgel Andrade EI; Leal Cherchiglia M; de Araújo VE
PLoS One; 2018; 13(6):e0199446. PubMed ID: 29928006
[TBL] [Abstract][Full Text] [Related]
12. Acute treatment costs of stroke in Brazil.
Christensen MC; Valiente R; Sampaio Silva G; Lee WC; Dutcher S; Guimarães Rocha MS; Massaro A
Neuroepidemiology; 2009; 32(2):142-9. PubMed ID: 19088487
[TBL] [Abstract][Full Text] [Related]
13. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study.
Bahia L; Coutinho ES; Barufaldi LA; Abreu Gde A; Malhão TA; de Souza CP; Araujo DV
BMC Public Health; 2012 Jun; 12():440. PubMed ID: 22713624
[TBL] [Abstract][Full Text] [Related]
14. Is the Risk Really Shared? A Retrospective Analysis of Healthcare Costs of Patients With Type 2 Diabetes Mellitus on a Capitation Model.
Naidoo LA; Butkow N; Barnard-Ashton P; Miot J; Libhaber E
Value Health Reg Issues; 2022 Mar; 28():29-37. PubMed ID: 34800829
[TBL] [Abstract][Full Text] [Related]
15. Cost of Type 2 Diabetes mellitus in Hong Kong Chinese.
Chan BS; Tsang MW; Lee VW; Lee KK
Int J Clin Pharmacol Ther; 2007 Aug; 45(8):455-68. PubMed ID: 17725179
[TBL] [Abstract][Full Text] [Related]
16. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of sickle cell disease in Brazil.
Silva-Pinto AC; Costa FF; Gualandro SFM; Fonseca PBB; Grindler CM; Souza Filho HCR; Bueno CT; Cançado RD
PLoS One; 2022; 17(6):e0269703. PubMed ID: 35709301
[TBL] [Abstract][Full Text] [Related]
18. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).
Ward A; Alvarez P; Vo L; Martin S
J Med Econ; 2014 Mar; 17(3):176-83. PubMed ID: 24410011
[TBL] [Abstract][Full Text] [Related]
19. Estimating the direct costs of ischemic heart disease: evidence from a teaching hospital in BRAZIL, a retrospective cohort study.
Schlatter RP; Hirakata VN; Polanczyk CA
BMC Cardiovasc Disord; 2017 Jul; 17(1):180. PubMed ID: 28676042
[TBL] [Abstract][Full Text] [Related]
20. ALBUMIN VERSUS STANDARD MEDICAL TREATMENT IN BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS.
Terra C; Viayna E; Ayzin L; Fuster C; Aceituno S; Tafla C
Arq Gastroenterol; 2023; 60(3):356-363. PubMed ID: 37792766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
